Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Breast Cancer. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Specialized Program of Research Excellence (SPORE) in Breast Cancer: Tissue and Specimen Collection
Overview
RATIONALE: Collecting and storing samples of tumor tissue from patients with breast cancer to study in the laboratory may help doctors learn more about cancer. PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.
Detailed description
OBJECTIVES:
Primary
* Collect breast tissue for future research from women undergoing surgery for breast cancer.
Secondary
* Create microarrays by tumor type for internal use by Specialized Program of Research Excellence.
OUTLINE: Tumor tissue is collected and analyzed to create microarrays by tumor type for future research studies.
PROJECTED ACCRUAL: A total of 1,250 patients will be accrued for this study.
Primary outcome measures
- Collect human breast tissues and associated clinical-pathologic data [Time frame: At time of diagnosis, surgery, and throughout standard care and clinical follow-up.]
Eligibility criteria
DISEASE CHARACTERISTICS:
- Undergoing surgery for breast cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago
Identifiers
NCT: NCT00898131 · NCI 01X1 · P50CA089018 · P30CA060553 · NU-NCI-01X1 · NCI-01X1 · STU00023488